Open access
Aug 2026
FMRP promotes gastric cancer progression via m6A-dependent stabilization of DVL2 and activation of the Wnt/PCP-JNK pathway
N6-methyladenosine (m6A) modification has emerged as a critical regulator in gastric cancer progression. Fragile X messenger ribonucleoprotein 1 (FMRP), an RNA-binding protein with tumorigenic potential, remains poorly characterized in gastric cancer. FMRP expression in gastric cancer was assessed through bioinformatic...
Xiao-Yu Hou, Jinlan Gao, Xue-Sha Xing et al.
· Journal of Translational Med... · 0 citations